Biocerna

Share on: 
Website: Biocerna
Description: 

Biocerna has developed PGx360™, a 22 gene, 62 genetic variation panel, designed to assist physicians in determining the most appropriate medications for their patients. Biocerna also performs translocations testing, typically used to monitor patients' responses to chemotherapy.

Location(s): 
Fulton MD
United States